General Information of the Compound
Compound ID
CP0578637
Compound Name
9-ethyl-2-(ethylamino)- 6-(3-(5-methyl-1,3,4- oxadiazol-2-yl)phenyl)- 6,7,8,9-tetrahydro-5H- pyrimido[4,5- e][1,4]diazepin-5-one
    Show/Hide
Structure
Formula
C20H23N7O2
Molecular Weight
393.451
Canonical SMILES
CCNc1ncc2c(n1)N(CC)CCN(c1cccc(c1)-c1nnc(C)o1)C2=O
    Show/Hide
InChI
InChI=1S/C20H23N7O2/c1-4-21-20-22-12-16-17(23-20)26(5-2)9-10-27(19(16)28)15-8-6-7-14(11-15)18-25-24-13(3)29-18/h6-8,11-12H,4-5,9-10H2,1-3H3,(H,21,22,23)
    Show/Hide
InChIKey
KHEAUDGDAOTKCC-UHFFFAOYSA-N
Physicochemical Property
logP
2.75352
Rotatable Bonds
5
Heavy Atom Count
29
Polar Areas
100.28
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
8
Complexity
29

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 132089220
ChEMBL ID
CHEMBL4790988
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01026, Sodium-dependent noradrenaline transporter
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS